Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
GOG Foundation
Sarcoma Alliance for Research through Collaboration
Amgen